[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f2QLukcj9VUEMzPC4d38aGAQvBXsLjmobgb8RJwyPEB8":8,"$f7G4J7YPKuWV73vd4W34fQ66t917RyQQVKSF0E74Dgm8":55,"$fKlWr3XsBDCnUmYOmPenwn412mZiLUaPeMdMskmUFdbA":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67029,867271,[],"https://ystcdn.venuertc.com/medical/ystApp/1KNmXQDnP2XagGmzBK1qyfRfTWA6Qk1r.png","李浩齐","缙云县新建镇中心卫生院","全科医疗","住院医师",516,0,"膀胱恶性肿瘤IV期治疗常用药品：安全用药全攻略","","https://ystcdn.venuertc.com/venue/AI/285f9a0b-138c-451b-aeae-ea05ec6db4ee.jpg","\u003Cdiv class=\"bladderdrug_material_wrap\">\n  \u003Ch2 id=\"material_title\" class=\"bladderdrug_material_title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">膀胱恶性肿瘤IV期治疗常用药品：安全用药全攻略\u003C/h2>\n  \n  \u003Cdiv class=\"bladderdrug_material_section bladderdrug_material_intro\" style=\"background:rgba(245,248,250,0.8); border-radius:16px; padding:24px; margin-bottom:32px;\">\n    \u003Cp style=\"font-size:19px; color:#3A3A3A;\">\n      说起来，膀胱恶性肿瘤IV期相关药品涵盖化疗、免疫治疗、手术辅助用药等多个类别。患者和家属会关心：什么剂型？如何用？哪些相互作用和不良反应需要警惕？本文为你梳理膀胱IV期治疗常用药品最重要的7个安全用药细节，每个细节配有实用操作建议，同时穿插真实用药案例，帮助你安心合理地用好每一种药品。\n    \u003C/p>\n  \u003C/div>\n\n\n  \u003Csection class=\"bladderdrug_material_section\" style=\"background:linear-gradient(90deg, #e8f0fe 0%, #fdf6eb 100%); border-radius:16px; margin-bottom:28px; padding:22px;\">\n    \u003Ch2 class=\"bladderdrug_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:1.6em;\">💊\u003C/span> 01 剂型及给药方式的关键区别\u003C/h2>\n    \u003Cul style=\"font-size:17px; color:#314157; line-height:2.1;\">\n      \u003Cli>\n        目前针对膀胱恶性肿瘤IV期常见的药品包括：\n        \u003Cstrong>静脉注射型化疗药\u003C/strong>（如顺铂、吉西他滨）、\u003Cstrong>免疫治疗药\u003C/strong>（如PD-1/PD-L1抑制剂）、以及部分口服辅助药物（如支持药、部分靶向药）。\n      \u003C/li>\n      \u003Cli>\n        正确做法：化疗药物大多通过静脉缓慢推注或泵入，间隔不宜随意调整。免疫治疗一般严格按照周期方案，通过静脉给药，不推荐自行变更剂量。\n      \u003C/li>\n      \u003Cli>\n        服用口服药需整片吞服，不要掰碎或嚼碎，配温水吞服，避免牛奶、含咖啡因饮品同服以免影响吸收。\n      \u003C/li>\n      \u003Cli>\n        个案：一位76岁女性患者接受膀胱灌注化疗和肾支架植入，强调每次药物灌注必须专业人员操作，家庭场景下不可自行操作。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003Csection class=\"bladderdrug_material_section\" style=\"background:linear-gradient(90deg, #f7fafc 0%, #e0f7fa 100%); border-radius:16px; margin-bottom:28px; padding:22px;\">\n    \u003Ch2 class=\"bladderdrug_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:1.6em;\">⌛\u003C/span> 02 最佳服药时间与周期管理\u003C/h2>\n    \u003Cul style=\"font-size:17px; color:#3b4957;\">\n      \u003Cli>\n        化疗药物和免疫药物均以疗程为单位管理，典型间隔为每3周至4周一次，连续多周期更有效，不建议随意中断或提前终止。\n      \u003C/li>\n      \u003Cli>\n        口服药物建议在\u003Cem>固定时间段\u003C/em>服用，早晚或饭前后需遵照说明书和医嘱，例如某些辅助药推荐早餐后或晚餐后服用，避免空腹刺激。\n      \u003C/li>\n      \u003Cli>\n        遗漏一次口服药时，正确做法是尽快补服（若距离下次服药超过12小时）；如临近下次服药，则跳过漏服，不可双倍添加。\n      \u003C/li>\n      \u003Cli>\n        个案：有患者因忘记服用辅助治疗药物，未按药品说明正确补服，导致疗效受影响，应建立\u003Cmark>日历提醒\u003C/mark>或使用药盒分装。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003Csection class=\"bladderdrug_material_section\" style=\"background:linear-gradient(90deg, #ffecb3 0%, #e3f2fd 100%); border-radius:16px; margin-bottom:28px; padding:22px;\">\n    \u003Ch2 class=\"bladderdrug_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:1.6em;\">📦\u003C/span> 03 储存条件与有效期把控\u003C/h2>\n    \u003Cul style=\"font-size:17px; color:#334d2c;\">\n      \u003Cli>\n        大多数化疗药和免疫制剂需低温（2-8℃）保存，不可冷冻，避免阳光直射，开封即用。口服药存于干燥、避光处，密封常温。\n      \u003C/li>\n      \u003Cli>\n        药品说明书通常注明有效期，过期药物应当弃置，不可继续使用（说明书显示大多数化疗药有效期为24个月，免疫制剂为12-18个月）。\n      \u003C/li>\n      \u003Cli>\n        化疗药如有肉眼可见沉淀、颜色异常，请勿注射，及时更换药品。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003Csection class=\"bladderdrug_material_section\" style=\"background:linear-gradient(90deg, #e1f5fe 0%, #fce4ec 100%); border-radius:16px; margin-bottom:28px; padding:22px;\">\n    \u003Ch2 class=\"bladderdrug_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:1.6em;\">⚠️\u003C/span> 04 药物相互作用及组合用药警示\u003C/h2>\n    \u003Cul style=\"font-size:17px; color:#154085;\">\n      \u003Cli>\n        化疗药如顺铂与利尿剂（如呋塞米）或肾毒性药物同用时有加重肾损伤风险，严禁患者自行组合，必须由医生评估。\n      \u003C/li>\n      \u003Cli>\n        免疫治疗药物不宜与大剂量糖皮质激素联用，否则会显著降低药效。\n      \u003C/li>\n      \u003Cli>\n        抗生素如头孢菌素可能影响免疫药品疗程，应分时段服用、需医生评估后安排，不要自行叠加抗感染药物。\n      \u003C/li>\n      \u003Cli>\n        服用抗凝药物期间（如患者VTE评分高危，需预防血栓），与化疗药物可能增加出血风险，务必由医生监控调整。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003Csection class=\"bladderdrug_material_section\" style=\"background:linear-gradient(90deg, #f0f4c3 0%, #fffde7 100%); border-radius:16px; margin-bottom:28px; padding:22px;\">\n    \u003Ch2 class=\"bladderdrug_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:1.6em;\">👥\u003C/span> 05 特殊人群用药调整细节\u003C/h2>\n    \u003Cul style=\"font-size:17px; color:#646464;\">\n      \u003Cli>\n        老年患者（如本案例76岁女性）需根据肾功能、体重等指标灵活调整化疗药物剂量，风险高者建议剂量减半。\n      \u003C/li>\n      \u003Cli>\n        妊娠和哺乳期妇女严禁使用绝大多数抗肿瘤药（说明书均明确禁忌）。\n      \u003C/li>\n      \u003Cli>\n        儿童使用剂型和剂量需严格遵循专业资料，总量按照体表面积换算，不可擅自增减。\n      \u003C/li>\n      \u003Cli>\n        肝肾功能不全者需提前告知医生，部分辅助药应替换或间隔延长。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n  \n  \u003Csection class=\"bladderdrug_material_section\" style=\"background:linear-gradient(90deg, #ede7f6 0%, #e8f5e9 100%); border-radius:16px; margin-bottom:28px; padding:22px;\">\n    \u003Ch2 class=\"bladderdrug_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:1.6em;\">🌡️\u003C/span> 06 常见不良反应应对办法\u003C/h2>\n    \u003Cul style=\"font-size:17px; color:#3E2723;\">\n      \u003Cli>\n        顺铂等化疗药品常见不良反应有脱发、恶心、肾功能下降。免疫治疗药可能导致皮疹、疲劳，少数有自身免疫激活（如肌炎）。\n      \u003C/li>\n      \u003Cli>\n        若出现异常反应（如持续呕吐、尿量明显减少、皮肤剧烈瘙痒），应立即联系医生，不可自行停药或加药。\n      \u003C/li>\n      \u003Cli>\n        说明书数据显示化疗药物恶心发生率约60%，但通过配套的止吐药（如昂丹司琼）可有效减轻不适。\n      \u003C/li>\n      \u003Cli>\n        一位患者在第13-15周期免疫治疗时出现轻微发热，经短期观察及对症处理后恢复，无需取消疗程。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003Csection class=\"bladderdrug_material_section\" style=\"background:linear-gradient(90deg, #e1bee7 0%, #fff3e0 100%); border-radius:16px; margin-bottom:28px; padding:22px;\">\n    \u003Ch2 class=\"bladderdrug_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:1.6em;\">🔁\u003C/span> 07 漏服和过量处理办法\u003C/h2>\n    \u003Cul style=\"font-size:17px; color:#455a64;\">\n      \u003Cli>\n        化疗和免疫制剂如漏服，仅能由医护人员根据方案调整，一般不允许随意补打或双倍剂量。\n      \u003C/li>\n      \u003Cli>\n        口服药漏服：如补服时距离下次服药超过12小时可正常补服，否则直接跳过，切忌一次性服两次剂量。\n      \u003C/li>\n      \u003Cli>\n        出现服药过量或明显异常时，正确做法是\u003Cstrong>立即携带药品包装前往医院急诊\u003C/strong>，医生会根据药品特性给予解毒或停药观察。\n      \u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003Csection class=\"bladderdrug_material_section\" style=\"background:#fafbfd; border-radius:16px; margin-bottom:32px; padding:26px;\">\n    \u003Ch2 class=\"bladderdrug_material_subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:1.6em;\">📑\u003C/span> 参考文献及数据出处\u003C/h2>\n    \u003Cul style=\"font-size:16px; color:#5f6368;\">\n      \u003Cli>\n        Bellmunt, J., de Wit, R., et al. (2017). \"Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.\" \u003Cem>The New England Journal of Medicine\u003C/em>, 376(11), 1015-1026.\n      \u003C/li>\n      \u003Cli>\n        von der Maase, H., Hansen, S. W., et al. (2000). \"Cisplatin-based Combination Chemotherapy in Advanced Bladder Cancer.\" \u003Cem>Journal of Clinical Oncology\u003C/em>, 18(17), 3068-3074.\n      \u003C/li>\n      \u003Cli>\n        Plimack, E. R., Flaig, T. W., et al. (2016). \"Gemcitabine and Cisplatin versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin for Bladder Cancer.\" \u003Cem>Journal of Clinical Oncology\u003C/em>, 34(16), 1940-1946.\u003C/li>\u003C/ul>\u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.bladderdrug_material_wrap {\n  font-family: \"PingFang SC\", \"Microsoft YaHei\", Arial, sans-serif;\n  max-width: 770px;\n  margin: 42px auto 38px auto;\n  background: #fff;\n  box-shadow: 0 4px 18px rgba(78,97,137,0.09);\n  border-radius: 18px;\n  padding: 26px 32px 24px 32px;\n}\n.bladderdrug_material_title {\n  font-size: 2.3em;\n  color: #283593;\n  margin-bottom: 28px;\n  text-align: center;\n  font-weight: bold;\n  letter-spacing: 1.2px;\n}\n.bladderdrug_material_subtitle {\n  font-size: 1.5em;\n  color: #3949ab;\n  font-weight: 600;\n  margin-bottom: 14px;\n  padding-left:2px;\n}\n.bladderdrug_material_section {\n  box-shadow: 0 2px 12px rgba(140,157,207,0.07);\n}\n.bladderdrug_material_section ul {\n  margin: 12px 0 0 10px;\n  padding-left: 18px;\n}\n.bladderdrug_material_section li {\n  margin-bottom: 12px;\n}\n.bladderdrug_material_intro p {\n  margin: 0;\n}\n@media (max-width: 780px) {\n  .bladderdrug_material_wrap {max-width: 97vw; padding:10px;}\n}\n.mark {\n  background: #ffd54f;\n  color: #222;\n  padding:0 4px;\n  border-radius:3px;\n}\n\u003C/style>\n","\u003Cdiv class=\"bladderdrug_material_wrap\">\n  \u003Ch2 id=\"material_title\" class=\"bladderdrug_material_title\"",325,"2025-09-23 14:54:46","膀胱癌, IV期治疗, 用药安全, 化疗药, 免疫治疗","本文梳理了膀胱恶性肿瘤IV期治疗药品的重要用药细节，帮助患者和家属合理安全用药，关注药物剂型、服药时间及不良反应，确保治疗效果。","2025-10-12 12:00:30",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]